Advantis Corp. (ADVT)

[buckyeye1978]

Ramoil Meeting With Potential Facility Partners in Multiple States and Countries

Sep 25, 2014 (eTeligis.com via COMTEX) -- LAS VEGAS, NV, United States, via ETELIGIS INC., 09/25/2014 - - RAMOIL MANAGEMENT, Ltd, (OTC Pink: RAMO) (PINKSHEETS: RAMO), would like to announce that it has begun to meet with and evaluate potential funding partners in multiple states, including California, Arizona, Nevada and Florida. In addition to this, RAMO Bio-Med, Inc. has opened conversations with potential international funding partners in Canada and Europe.
Michael Goeree, the Company's Chairman, President and Chief Executive Officer, said, "Each RAMO Bio-Med Lab, Extraction Facility and Medibles Commercial Kitchen is estimated to cost about $1.5 Million to build and should produce in excess of $10 Million in Revenues, per facility, per year. We have been overwhelmed with interest from potential investment groups, to partner with us in multiple State Markets, as well as International Markets and have begun the process of qualifying the appropriate potential partner groups in each market."

Mr. Goeree further stated, "I could not be more excited about Ramoil Management's or RAMO Bio-Med's future and its shareholder's futures, than I am at this moment."

About Ramoil Management, Ltd.

Ramoil Management, Ltd. (RAMO) is a development stage company. The Company is an online wholesaler of E-cigarettes containing nutraceutical vapor oils, E-cigarette delivery systems and hydroponic lighting and nutrients.

About RAMO Bio-Med, Inc.

RAMO Bio-Med, Inc. is a wholly owned subsidiary of Ramoil Management, Ltd. (RAMO) and is a development stage company. The Company is the operating company of the newly acquired "Supercritical CO2 Molecular Extraction Technology" and will be building operating production facilities and research labs, both domestically and internationally, focused on its own proprietary strain of High CBD Extremely Low THC "Charlottes Webb" and Extraction Facilities (Labs and Manufacturing), for the development, production and sales of CBD extractions, concentrates and medicines.

Forward Looking Statements:

This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.

CONTACT:

Company and Investor Relations Contact:

Frank Blainey, Esq.

1-702-381-1961

[e-mail]

SOURCE Ramoil Management, Ltd.

Associated Documentation:

http://www.eteligis.com/ViewSubmission.aspx?submissionRequest=27909 - Link to submission on http://www.eteligis.com

http://www.eteligis.com/FileHandler.aspx?submissionRequest=27909&documentRequest=18199 - RAMO_9-25-2014_PAP_ETL.docx

Copyright Eteligis Inc. 2014. All rights reserved.
-0-
INDUSTRY KEYWORD: HEALTH
MANUFACTURING
MEDICAL
SUBJECT CODE: COA
JVN